Compare JJSF & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | NVAX |
|---|---|---|
| Founded | 1971 | 1987 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | Specialty Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 1995 | 1996 |
| Metric | JJSF | NVAX |
|---|---|---|
| Price | $84.82 | $9.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 9 |
| Target Price | ★ $138.33 | $10.78 |
| AVG Volume (30 Days) | 290.0K | ★ 3.9M |
| Earning Date | 05-05-2026 | 04-07-2026 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | N/A | ★ 77.26 |
| EPS | 0.05 | ★ 2.53 |
| Revenue | ★ $1,022,038,000.00 | $682,162,000.00 |
| Revenue This Year | $0.87 | $58.91 |
| Revenue Next Year | $1.88 | N/A |
| P/E Ratio | $1,693.00 | ★ $3.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $80.00 | $5.01 |
| 52 Week High | $144.37 | $10.63 |
| Indicator | JJSF | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 58.44 |
| Support Level | $80.23 | $8.01 |
| Resistance Level | $96.97 | $10.42 |
| Average True Range (ATR) | 4.12 | 0.55 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 33.34 | 79.50 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.